Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Artelo Biosciences, Inc. (ARTL) had Return on Investments of -343.93% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-9.83M |
|
-- |
|
-- |
|
$10.11M |
|
$-10.11M |
|
$0.28M |
|
$-9.83M |
|
$-10.11M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-10.11M |
|
$-10.11M |
|
$-10.11M |
|
3.22M |
|
3.22M |
|
$-3.05 |
|
$-3.05 |
|
| Balance Sheet Financials | |
$2.56M |
|
-- |
|
$2.14M |
|
$4.70M |
|
$1.77M |
|
-- |
|
$0.07M |
|
$1.84M |
|
$2.86M |
|
$0.82M |
|
$2.86M |
|
3.28M |
|
| Cash Flow Statement Financials | |
$-8.35M |
|
$7.77M |
|
$0.11M |
|
$2.81M |
|
$2.34M |
|
$-0.48M |
|
$0.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-343.93% |
|
-1201.22% |
|
-209.15% |
|
|
Return on Investments |
-343.93% |
$0.87 |
|
$-2.59 |
|
$-2.59 |
|